Mental illnesses are prevalent in the United States and globally. Cost is a critical barrier to treatment receipt. We study the effects of the Affordable Care Act's recent expansion of Medicaid, a public insurance system for the poor in the U.S., on psychotropic prescription medications for mental illness. We estimate differences-in-differences models using administrative data on medications for which Medicaid was a third-party payer over the period 2011–2017. Our findings suggest that these expansions increased psychotropic prescriptions by 21.0%. We show that Medicaid, and not patients, financed these prescriptions. For states expanding Medicaid, the total cost of these prescriptions was $28.0 M by the second quarter of 2017. Expansion effects were experienced across most major mental illness categories and across states with different levels of patient need, system capacity, and expansion scope. We find no statistically significant evidence that Medicaid expansion reduced mental illness.
Contents
- Research Articles
-
Requires Authentication UnlicensedPublic Health Insurance and Prescription Medications for Mental IllnessLicensedSeptember 29, 2018
-
Requires Authentication UnlicensedInter-Ethnic Friendship and Hostility between Roma and non-Roma Students in Hungary: The Role of Exposure and Academic AchievementLicensedOctober 6, 2018
-
Requires Authentication UnlicensedThe Costs of Firm Exit and Labour Market Policies: New Evidence from EuropeLicensedOctober 11, 2018
-
Requires Authentication UnlicensedParental Transfers, Intra-household Bargaining and Fertility DecisionLicensedOctober 12, 2018
-
Requires Authentication UnlicensedDo Firms Supported by Credit Guarantee Schemes Report Better Financial Results 2 Years After the End of Intervention?LicensedOctober 26, 2018
-
Requires Authentication UnlicensedEstimating the Impact of Ride-Hailing App Company Entry on Public Transportation Use in Major US Urban AreasLicensedDecember 12, 2018
-
Requires Authentication UnlicensedAnnounced or Surprise Inspections and Oligopoly CompetitionLicensedDecember 15, 2018
-
Requires Authentication UnlicensedTerrorism and Firm Performance: Empirical Evidence from PakistanLicensedDecember 15, 2018
-
Requires Authentication UnlicensedThe Curious Case of Farmer Credit Cards: Evidence from an Indian Policy ReformLicensedJanuary 5, 2019
-
Requires Authentication UnlicensedPopulation Policy, Demographic Change, and Firm Returns: Evidence from ChinaLicensedJanuary 5, 2019
-
Requires Authentication UnlicensedSorting into Contests: Evidence from Production ContractsLicensedJanuary 5, 2019
-
Requires Authentication UnlicensedShe-E-Os and the Cost of Debt: Do Female CEOs Pay Less for Credit?LicensedSeptember 25, 2018